Immuno-deficiency acquired during carcinogenesis: a mechanism facilitating cancer development.
D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects*; D002273:Carcinogens; D008264:Macrophages / Q000187:drug effects*; D051379:Mice; D009183:Mycotoxins / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D013491:Suppressor Factors, Immunologic; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects / Q000276:immunology; D013755:Tetradecanoylphorbol Acetate / Q000031:analogs & derivatives* / Q000494:pharmacology
D002273:Carcinogens; D009183:Mycotoxins; D011090:Polyenes; D013491:Suppressor Factors, Immunologic; C032975:12-O-tetradeca-2,4,6,8-tetranoylphorbol-13-acetate; C041403:fusarin C; D013755:Tetradecanoylphorbol Acetate